Photo of Erin D. Ellis

Erin D. Ellis, M.D.

About

Professional Statement

I see my role as an educator, discussing each patients medical problems in detail. I work with the patient to formulate a treatment plan. I would describe my practice style as very "interactive.

Read More

Accepts 43 Insurance Plans

Please contact the practice directly to confirm your health plan is accepted
  • Aetna Medicare Advantage HMO
  • Aetna Medicare Advantage PPO
  • Aetna PPO
  • Amerigroup Amerivantage Dual Coordination
  • Amerigroup Amerivantage HMO
  • Amerigroup Medicaid (Apple Health/Healthy Options/CHIP)
  • Beacon Health Options PPO (Behavioral Health)
  • CHPW Medicaid (Apple Health/Healthy Options/CHIP)
  • CHPW Medicare Advantage
  • Cigna Behavioral Health
  • Cigna PPO
  • Coordinated Care Ambetter HMO
  • Coordinated Care Medicaid (Apple Health/Healthy Options/CHIP)
  • Coventry/First Health PPO
  • First Choice PPO
  • HealthSmart (Interplan) PPO
  • Humana Medicare Advantage
  • Humana PPO
  • Kaiser (Contract Limitations)
  • Medicaid of Washington
  • Medicare
  • Molina Exchange HMO
  • Molina Medicaid (Apple Health/Healthy Options/CHIP)
  • Molina Medicare Advantage
  • Multiplan PPO
  • Optum
  • PacMed USFHP
  • Premera Heritage
  • Premera Heritage Signature
  • Premera Medicare Advantage HMO
  • Providence Health Plan Medicare Advantage
  • Regence MedAdvantage PPO
  • Regence PPO
  • TRICARE
  • Triwest VAPC3/Choice Card
  • United Behavioral Health Medicaid
  • United Behavioral Health Medicare Advantage
  • United Behavioral Health PPO
  • United HealthCare HMO
  • United HealthCare Medicaid (Apple Health/Healthy Options/CHIP)
  • United HealthCare Medicare Advantage
  • United HealthCare PPO
  • Workers' Compensation (L&I)
Read More

Education

Johns Hopkins University School of Medicine
medical school
Michael Reese Hospital and Medical Center
residency
University of Chicago Medical Center, IL
fellowship

Board Certifications

American Board of Internal Medicine
Internal Medicine
American Board of Internal Medicine
Oncology

Clinical Interests

  • Abnormal Mammogram
  • Aromatase Inhibitor
  • Breast Cancer
  • Breast Cancer Chemotherapy
  • Breast Cancer Follow Up
  • Breast Cancer Genetics
  • Breast Cancer Genomics
  • Cancer
  • Cancer Chemotherapy
  • Cancer During Pregnancy
  • Cancer Genomics
  • Cancer Survivorship
  • Carcinoma In Situ Of Breast
  • Dysplasia Of Breast
  • Egfr Mutation
  • Endocrine Complications Of Cancer Therapy
  • Er Positive Breast Cancer
  • Family History Of Breast Cancer
  • Genetic Counseling
  • Herceptin
  • Hormone Replacement Therapy
  • Male Breast Cancer
  • Mammogram
  • Metastatic Breast Cancer
  • Microcalcifications
  • Plasma Cell Dyscrasia
  • Pulmonary Metastases
  • Radiation Treatment For Breast Cancer
  • Sentinel Node Biopsy
  • Teratogen Exposure
  • Unknown Primary Cancer
Read More

Publications

  • Dr. Erin Ellis is the lead investigator for the following clinical trials currently available at the Swedish Cancer Institute:
    I-SPY 2 Trial (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging And moLecular Analysis 2) A Randomized Phase 2 Study of the Efficacy and Tolerability of Veliparib in Combination with Temozolomide or Veliparib in Combination with Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Subjects with BRCA1 or BRCA2 Mutation and Metastatic Breast Cancer
  • WI Bensinger, KS Schiffman, L Holmberg, FR Appelbaum, R Maziarz, P Montgomery, E Elllis, S Rivkin, P Weiden, et al. High-dose busulfan, melphalan, thiotepa, and peripheral blood stem cell infusion for the treatment of metastatic breast cancer. Bone Marrow Transplanation, 1997.
  • Golom HM and Ellis E. Treatment options for hairy cell leukemia. Seminars in Oncology, 18: 7-11, 1991.
  • Ellis ED, Williams, SF and Golomb HM. Current advances and guidelines in therapy. In benign and malignant lymphadenopathies: A Guide to Clinical and Laboratory Diagosis, edited by GA Pangalis and A Polliak.
  • Moormeier JA, Williams SF, Kaminer LS, Ellis ED, Garner M, Farah, Weichselbaum RR, and Bitran JD. Autologous bone marrow transplantation followed by involved field radiotherapy in aptients with relapsed or refractory Hodgkin’s disease. Leukemia and Lymphoma.
  • Ellis ED, Williams, SF, moormeier JA, Mainer LS, and Bitran JD. A phase I-II study of high dose cyclophosphamide, thiotepa and escalating doses of mitoxantrone with autologous stem cell rescue in patients with refractory malignancies. Bone Marrow Transplatnation, 6: 439-442, 1990.
  • Ellis ED, Moormeier JA and Golomb HM. The treatment of hairy cell leukemia; a review. Leukemia and Lymphoma, 1: 77-85, 1990.
  • Le Beau MM, Bitter MA, Larson RA, Doane LA, Ellis ED, Franklin WA, Rubin CM, Kadin ME and Varidman JW. The t(2;5)(p23;q35): A recurring chromosomal abnormality in Ki-1 positive anaplastic large cell lymphoma. Leukemia, 3: 866-870, 1989.
  • Ellis E, Vokes E, Hoffman P, Krishnasamy S, Gradishar W, English C, Ferguson M, Haraf D, Bitran J and Golomb H. A phase II study of neoadjuvant chemotherapy and concomitant chemoradiotherapy for stage III lung cancer. Proceedings of ASCO, 1991.
  • Bitran JD, Vokes EE, Hoffman PC, Ellis ED, Gradishar W and Golomb HM. Combines modality therapy for stage III non-small cell lung cancer (NSCLC). Third International Congress on Neoadjuvant Chemotherapy, February 6-9, 1991.
  • Ellis ED, Williams SF, Moormeier JA, Bitran JD and Ratain MJ. A phase I study of high dose amonafide with autologous bone marrow rescue (ABMR). American Federation for Clinical Research, Midwest Section, November 1, 1990.
  • Ellis E, Moormeier J, Williams S, Kaminer L, Mick R, Bitran J. A phase II study of mitoxantrone, vincristine, and 5-fluorouracil with leucovorin (MVFL) as induction chemotherapy in women with stage IV breast cancer. 13th Annual San Antonio Breast Cancer Symposium, November 2-3, 1990.
  • Ellis E, Moormeier J, Kaminer L, Mick R, Williams S and Bitran J. A phase I-II study of high dose cyclophosphamide, thiotepa and mitoxantrone (CTM) in autologous bone marrow reinfusion (ABMR) in patients with refractory malignancies. Proceedings of ASCO, 9: 17, 1990.
Read More

Languages

  • English

Practice Locations

Erin D. Ellis practices at one location

Medical Oncology First Hill - True Center
1221 Madison Street
Floor 5

Seattle, WA 98104
Affiliated Facilities
  • Swedish Cherry Hill
  • Swedish First Hill
Medical Groups
Swedish Medical Group logo